Cargando…

Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer

BACKGROUND: Several studies have shown the prognostic and predictive potential of molecular markers in combined therapy for lung cancer. Most of them referred, however, to operable early stage NSCLC. The aim of the present study is to correlate the expression of multiple mRNA markers in bronchoscopy...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwinski, Rafal, Klusek, Artur, Tyszkiewicz, Tomasz, Kowalska, Maria, Szczesniak-Klusek, Bogna, Gawkowska-Suwinska, Marzena, Tukiendorf, Andrzej, Kozielski, Jerzy, Jarzab, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407200/
https://www.ncbi.nlm.nih.gov/pubmed/22848476
http://dx.doi.org/10.1371/journal.pone.0041379
_version_ 1782239309480329216
author Suwinski, Rafal
Klusek, Artur
Tyszkiewicz, Tomasz
Kowalska, Maria
Szczesniak-Klusek, Bogna
Gawkowska-Suwinska, Marzena
Tukiendorf, Andrzej
Kozielski, Jerzy
Jarzab, Michal
author_facet Suwinski, Rafal
Klusek, Artur
Tyszkiewicz, Tomasz
Kowalska, Maria
Szczesniak-Klusek, Bogna
Gawkowska-Suwinska, Marzena
Tukiendorf, Andrzej
Kozielski, Jerzy
Jarzab, Michal
author_sort Suwinski, Rafal
collection PubMed
description BACKGROUND: Several studies have shown the prognostic and predictive potential of molecular markers in combined therapy for lung cancer. Most of them referred, however, to operable early stage NSCLC. The aim of the present study is to correlate the expression of multiple mRNA markers in bronchoscopy obtained cancer specimens with clinical outcome of advanced lung cancer. METHODS: Bronchoscopy cancer specimens were taken from 123 patients with radiological diagnosis of advanced lung tumor. Out of 123 patients 50 were diagnosed with squamous cell cancer, 17 with adenocarcinoma, 12 with NOS, 32 with SCLC and one with large cell neuroendocrinal cancer. In 11 patients other tumours were diagnosed. The group was heterogeneous with respect to clinical stage, performance of the patients and treatment. Quantitative real time PCR was carried out by ABI 7900 HT machine, with Universal Probe Library (Roche) fluorescent probes. The genes selected for the analysis were ERCC1, EGFR, BRCA1, CSF1, CA9, DUSP6, STAT1, ERBB3, MMD, FN1, and CDKN1B. RESULTS: More than 50 ng of RNA (the amount considered sufficient for the analysis) was isolated in 82 out of 112 lung cancer specimens (73%), including 60/80 (75.0%) of NSCLC specimens and 22/32 (68,7%) of SCLC samples. The highest Cohen’s κ coefficient for discrimination between small cell, squamous cell and adenocarcinoma was found for CDKN1B, CSF and EGFR1 (κ = 0.177, p = 0.0041). A multivariate Cox regression model has shown a significant impact of clinical stage (p<0.001, RR = 4.19), ERCC1 (p = 0.01, RR = 0.43) and CA9 (p = 0.03, RR = 2.11) expression on overall survival in a group of 60 patients with NSCLC. CONCLUSION: These results show the feasibility of multiple gene expression analysis in bronchoscopy obtained cancer specimens as prognostic markers in radiotherapy and chemotherapy for advanced lung cancer. A limiting factor was relatively high proportion of samples from which sufficient amount of RNA could not be isolated.
format Online
Article
Text
id pubmed-3407200
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34072002012-07-30 Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer Suwinski, Rafal Klusek, Artur Tyszkiewicz, Tomasz Kowalska, Maria Szczesniak-Klusek, Bogna Gawkowska-Suwinska, Marzena Tukiendorf, Andrzej Kozielski, Jerzy Jarzab, Michal PLoS One Research Article BACKGROUND: Several studies have shown the prognostic and predictive potential of molecular markers in combined therapy for lung cancer. Most of them referred, however, to operable early stage NSCLC. The aim of the present study is to correlate the expression of multiple mRNA markers in bronchoscopy obtained cancer specimens with clinical outcome of advanced lung cancer. METHODS: Bronchoscopy cancer specimens were taken from 123 patients with radiological diagnosis of advanced lung tumor. Out of 123 patients 50 were diagnosed with squamous cell cancer, 17 with adenocarcinoma, 12 with NOS, 32 with SCLC and one with large cell neuroendocrinal cancer. In 11 patients other tumours were diagnosed. The group was heterogeneous with respect to clinical stage, performance of the patients and treatment. Quantitative real time PCR was carried out by ABI 7900 HT machine, with Universal Probe Library (Roche) fluorescent probes. The genes selected for the analysis were ERCC1, EGFR, BRCA1, CSF1, CA9, DUSP6, STAT1, ERBB3, MMD, FN1, and CDKN1B. RESULTS: More than 50 ng of RNA (the amount considered sufficient for the analysis) was isolated in 82 out of 112 lung cancer specimens (73%), including 60/80 (75.0%) of NSCLC specimens and 22/32 (68,7%) of SCLC samples. The highest Cohen’s κ coefficient for discrimination between small cell, squamous cell and adenocarcinoma was found for CDKN1B, CSF and EGFR1 (κ = 0.177, p = 0.0041). A multivariate Cox regression model has shown a significant impact of clinical stage (p<0.001, RR = 4.19), ERCC1 (p = 0.01, RR = 0.43) and CA9 (p = 0.03, RR = 2.11) expression on overall survival in a group of 60 patients with NSCLC. CONCLUSION: These results show the feasibility of multiple gene expression analysis in bronchoscopy obtained cancer specimens as prognostic markers in radiotherapy and chemotherapy for advanced lung cancer. A limiting factor was relatively high proportion of samples from which sufficient amount of RNA could not be isolated. Public Library of Science 2012-07-27 /pmc/articles/PMC3407200/ /pubmed/22848476 http://dx.doi.org/10.1371/journal.pone.0041379 Text en © 2012 Suwinski et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Suwinski, Rafal
Klusek, Artur
Tyszkiewicz, Tomasz
Kowalska, Maria
Szczesniak-Klusek, Bogna
Gawkowska-Suwinska, Marzena
Tukiendorf, Andrzej
Kozielski, Jerzy
Jarzab, Michal
Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title_full Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title_fullStr Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title_full_unstemmed Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title_short Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
title_sort gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407200/
https://www.ncbi.nlm.nih.gov/pubmed/22848476
http://dx.doi.org/10.1371/journal.pone.0041379
work_keys_str_mv AT suwinskirafal geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT klusekartur geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT tyszkiewicztomasz geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT kowalskamaria geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT szczesniakklusekbogna geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT gawkowskasuwinskamarzena geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT tukiendorfandrzej geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT kozielskijerzy geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer
AT jarzabmichal geneexpressionfrombronchoscopyobtainedtumoursamplesasapredictorofoutcomeinadvancedinoperablelungcancer